- Home
- SUPN vs NTB Comparison
SUPN vs NTB Comparison
Compare SUPN & NTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SUPN | NTB |
|---|---|---|
| Founded | 2005 | 1858 |
| Country | United States | Bermuda |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Commercial Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.1B |
| IPO Year | 2012 | 2016 |
Fundamental Metrics
Financial Performance| Metric | SUPN | NTB |
|---|---|---|
| Price | $49.74 | $50.09 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 3 |
| Target Price | ★ $61.60 | $50.67 |
| AVG Volume (30 Days) | ★ 634.2K | 157.5K |
| Earning Date | 11-04-2025 | 02-09-2026 |
| Dividend Yield | N/A | ★ 3.97% |
| EPS Growth | N/A | ★ 17.07 |
| EPS | N/A | ★ 5.27 |
| Revenue | ★ $681,539,000.00 | $599,452,000.00 |
| Revenue This Year | $8.32 | $4.72 |
| Revenue Next Year | $23.36 | N/A |
| P/E Ratio | ★ N/A | $9.56 |
| Revenue Growth | 4.54 | ★ 4.60 |
| 52 Week Low | $29.16 | $34.77 |
| 52 Week High | $57.65 | $52.11 |
Technical Indicators
Market Signals| Indicator | SUPN | NTB |
|---|---|---|
| Relative Strength Index (RSI) | 56.15 | 60.60 |
| Support Level | $51.01 | $50.50 |
| Resistance Level | $52.30 | $52.11 |
| Average True Range (ATR) | 1.40 | 0.86 |
| MACD | 0.35 | -0.25 |
| Stochastic Oscillator | 64.48 | 34.83 |
Price Performance
Historical ComparisonAbout SUPN Supernus Pharmaceuticals Inc.
Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.
About NTB Bank of N.T. Butterfield & Son Limited (The) Voting
Bank of N.T Butterfield & Son Ltd is a full-service bank and wealth manager. It operates the business through three geographic segments, Bermuda, Cayman Islands, the Channel Islands and the UK. The company offers banking services, comprised of retail and corporate banking, and wealth management, which consists of trust, private banking, and asset management. The company generates a majority of its revenue from Bermuda, and the Cayman Islands segments.